Podiatrist, Foot Surgery · Brooklyn, NY
NPI
1811154339
Since 2008
Specialty
Podiatrist, Foot Surgery
Code 213ES0131X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
1505b Mermaid Ave
Brooklyn, NY, 11224
Phone (718) 758-5043
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
155 services
Medicare patients, 2024
33
Average age 73
Drug cost, 2024
$1.2M
1,445 prescriptions
Company payments, 2023
$159
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark V Morano was code 99213 (office e&m - established), 90 times for 27 patients. In total Mark V Morano billed 155 services in 8 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 90 | 27 | $73.52 | $6,616 |
| 99203 Office E&M - New | Office | 11 | 11 | $92.34 | $1,016 |
By year: 2022 $14K for 196 services; 2023 $12K for 146 services; 2024 $12K for 155 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark V Morano prescribed most often to Medicare patients was Clobetasol Propionate, with 297 prescriptions and refills. In total Mark V Morano wrote 1,445 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 297 | 432 | 79 | $177K |
| Doxepin Hcl Generic | 243 | 263 | 98 | $177K |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 82 | 82 | 34 | $17K |
| Betamethasone Dipropionate Generic | 75 | 97 | 25 | $12K |
| Chlorpromazine Hcl Generic | 69 | 69 | 30 | $55K |
| Budesonide Er Budesonide | 59 | 59 | 17 | $57K |
| Fluconazole Generic | 56 | 57 | 24 | $34K |
| Jublia Efinaconazole | 56 | 56 | Under 11 | $75K |
| Naftifine Hcl Generic | 54 | 54 | 24 | $28K |
| Ketoconazole Generic | 52 | 52 | 15 | $8,210 |
| Ammonium Lactate Generic | 45 | 47 | 20 | $897 |
| Fluocinonide Generic | 42 | 49 | 27 | $15K |
| Ciclopirox Generic | 33 | 35 | Under 11 | $3,045 |
| Diflorasone Diacetate Generic | 28 | 34 | 14 | $21K |
| Naproxen Sodium Er Naproxen Sodium | 27 | 27 | 11 | $43K |
Brand drugs: 356 claims; generic drugs: 1,089 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Mark V Morano $159 ($159 in general payments such as food, travel and fees) from 1 company. The largest payer was Treace Medical Concepts, Inc. with $159.
| Company | Payments | Amount |
|---|---|---|
| Treace Medical Concepts, Inc. TMCI | 1 | $159 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.